Thomas Flaig, MD, University of Colorado Anschutz Medical Campus (IMAGE)

University of Colorado Anschutz Medical Campus

Thomas Flaig, MD, University of Colorado Anschutz Medical Campus

Caption

Thomas Flaig, MD, describes the use of gold nanoparticles, lasers, antibodies and bioluminescence to target bladder cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

with attribution

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.